Number of private and IPO biotechnology companies in Germany 2009-2022
In 2022, there were 727 private biotechnology companies in Germany. There were 23 IPO companies. The number of private companies peaked in 2020 at 740.
Number of private and IPO biotechnology companies in Germany from 2009 to 2022
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Biotechnology in Germany
Overview
8
- Premium Statistic 2024 list of global top 10 biotech and pharmaceutical companies based on revenue
- Basic Statistic European countries based on number of public biotech companies 2021
- Premium Statistic Revenue of top biotech and pharmaceutical companies in Germany 2024
- Basic Statistic Biotechnology companies in Germany from 2006 to 2023
- Premium Statistic Private and listed biotechnology companies in Germany from 2009 to 2022
- Premium Statistic Number of dedicated biotechnology companies in Germany 2022, by area of focus
- Premium Statistic Number of medical biotechnology companies in Germany 2010-2023
- Premium Statistic Survey on the current business situation of biotech companies in Germany 2007-2024
Biopharmaceutical market
8
- Basic Statistic Enterprise value change in biopharma subsectors worldwide 2022-2023
- Premium Statistic Market capitalization of top biotech and pharmaceutical companies in Germany 2024
- Premium Statistic Revenue development in biotechnology companies in Germany from 2007 to 2022
- Premium Statistic Revenue development of biopharmaceuticals in Germany from 2008 to 2023
- Premium Statistic Revenue development in the German biotech industry 1999-2022
- Premium Statistic Revenues of biopharmaceutical companies in Germany from 2007 to 2023
- Premium Statistic Biopharmaceutical approvals in Germany 2020-2023, by drug type
- Premium Statistic Biopharmaceutical revenues in Germany in 2023, by application field
Research and components
6
- Premium Statistic R&D expenditure of biotechnology companies in Germany from 2009 to 2022
- Premium Statistic R&D spending development in biotechnology companies in Germany from 2007 to 2022
- Premium Statistic Biopharmaceuticals new registrations in Germany 2000-2023
- Premium Statistic Biopharmaceuticals: new registrations share in Germany 2000-2023
- Premium Statistic Biopharmaceutical drugs in Germany 2008-2023, by stage of development
- Premium Statistic Biopharmaceuticals in the development pipeline in Germany 2023, by disease group
Funding
4
- Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2023
- Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2023
- Premium Statistic Financial sources for biotechnology companies in Germany 2005 to 2022
- Premium Statistic Number of private and IPO biotechnology companies in Germany 2009-2022
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
EY. (June 1, 2023). Number of private and IPO biotechnology companies in Germany from 2009 to 2022 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/
EY. "Number of private and IPO biotechnology companies in Germany from 2009 to 2022." Chart. June 1, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/
EY. (2023). Number of private and IPO biotechnology companies in Germany from 2009 to 2022. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/
EY. "Number of Private and Ipo Biotechnology Companies in Germany from 2009 to 2022." Statista, Statista Inc., 1 Jun 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/
EY, Number of private and IPO biotechnology companies in Germany from 2009 to 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/ (last visited November 10, 2024)
Number of private and IPO biotechnology companies in Germany from 2009 to 2022 [Graph], EY, June 1, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1461441/private-ipo-biotech-companies-germany/